OrbiMed Advisors LLC, a renowned investment firm, recently executed a significant transaction involving NeuroPace Inc. This article provides an in-depth analysis of the transaction, the profiles of both the guru and the traded company, and the potential implications of the transaction on the market. The transaction took place on October 3, 2023, with OrbiMed Advisors LLC reducing its stake in NeuroPace Inc. The firm sold 8,314 shares at a trading price of $9.07 per share, leaving it with a total of 4,003,967 shares in the company.